ENTITY
Tianjin Fund
Tianjin Fund
PulseAugur coverage of Tianjin Fund — every cluster mentioning Tianjin Fund across labs, papers, and developer communities, ranked by signal.
Total · 30d
0
2 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TOPICS
RECENT · PAGE 1/1 · 2 TOTAL
-
Fosun Pharma invests 414M yuan in liver disease drug developer Xingyao Kunze
Fosun Pharma is investing 414 million yuan in a Series B funding round for Xingyao Kunze, a company focused on innovative liver disease drugs. This investment, which includes acquiring shares from existing shareholders,…
-
Fosun Pharma invests 414M yuan in liver disease drug developer Starry Kunze
Fosun Pharma's subsidiary, Fosun Pharma Industry, is investing 414 million yuan in Starry Kunze's Series B funding round. This investment includes subscribing to new capital and acquiring existing shares, which will res…